Seattle Genetics requests arbitration to resolve Daiichi Sankyo dispute

Seattle Genetics has asked the American Arbitration Association (AAA) to help resolve a dispute with Daiichi Sankyo, alleging that the Japanese pharma company used its technology to create a number of drugs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Daiichi Sankyo unit accuses Pharmacosmos of patent infringement

12 February 2020 American Regent, the US subsidiary of pharmaceutical company Daiichi Sankyo, has taken iron therapy specialist Pharmacosmos to court over an injectable treatment for anaemia.

Big Pharma

AstraZeneca and Daiichi Sankyo to develop new cancer treatment

2 April 2019 Biopharmaceutical company AstraZeneca has entered into an agreement with Japanese pharmaceutical company Daiichi Sankyo to develop and commercialise trastuzumab deruxtecan, a potential new medicine for cancer treatment.

Americas

Seattle Genetics to acquire biotech company for $614m

2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.

More on this story

Americas

Daiichi Sankyo unit accuses Pharmacosmos of patent infringement

12 February 2020 American Regent, the US subsidiary of pharmaceutical company Daiichi Sankyo, has taken iron therapy specialist Pharmacosmos to court over an injectable treatment for anaemia.

Big Pharma

AstraZeneca and Daiichi Sankyo to develop new cancer treatment

Americas

Seattle Genetics to acquire biotech company for $614m

2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.

More on this story

Americas

Daiichi Sankyo unit accuses Pharmacosmos of patent infringement

12 February 2020 American Regent, the US subsidiary of pharmaceutical company Daiichi Sankyo, has taken iron therapy specialist Pharmacosmos to court over an injectable treatment for anaemia.

Big Pharma

AstraZeneca and Daiichi Sankyo to develop new cancer treatment

Americas

Seattle Genetics to acquire biotech company for $614m

2 February 2018 Seattle Genetics has announced that it will acquire biotech company Cascadian Therapeutics for approximately $614 million.